Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Multiepitope Peptide Vaccination in Combination With Adjuvants GM-CSF and KLH in Metastatic Melanoma

NCT00153569 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT00153569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00153569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Multiepitope Peptide Vaccination in Combination With Adjuvants GM-CSF and KLH in Metastatic Melanoma
Lead sponsor
Charite University, Berlin, Germany
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2003
Completion date
September 30, 2005
Enrollment
25
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma